Merck (MRK) Q2 2025 Earnings Call Transcript
Company Participants
- Operator
- Peter Dannenbaum - SVP - IR, Merck & Co
- Robert Davis - Chairman & CEO, Merck & Co
- Caroline Litchfield - EVP & CFO, Merck & Co
- Dean Li - EVP & President - Merck Research Laboratories, Merck & Co
- Daina Graybosch - Senior MD - Immuno-Oncology, Leerink Partners
- Vamil Divan - MD & Senior Research Analyst, Guggenheim Securities, LLC
- Chris Schott - Managing Director, JP Morgan
- Asad Haider - Healthcare Analyst, Goldman Sachs
- Evan Seigerman - MD & Senior Research Analyst, BMO Capital Markets
- Umer Raffat - Senior Managing Director, Evercore ISI
- Akash Tewari - Global Head - Biopharmaceutical Research, Jefferies
- Terence Flynn - Equity Research Analyst, Morgan Stanley
- Courtney Breen - Senior Research Analyst, Bernstein
- Trung Huynh - Executive Director & Equity Research, UBS Group
- Tim Anderson - Managing Director, Senior Equity Research Analyst, Bank of America
- Alexandria Hammond - Director - Head of Therapeutics, Wolfe Research LLC
- James Shin - Director - Biopharma Equity Research, Deutsche Bank
- Mohit Bansal - Managing Director, Wells Fargo Securities